Liver Cirrhosis: all 1,668 studies
Page 13 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCTStatus unknownNCT02630095Phase 4
- Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver CirrhosisStatus unknownNCT02621372
- Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of AscitesTerminatedNCT02612519Not applicable
- Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With AscitesCompletedNCT02608658Not applicable
- Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of SepsisTerminatedNCT02602210Phase 3
- Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 InfectionCompletedNCT02597166Phase 3
- Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) CirrhoticsCompletedNCT02596880Phase 3
- Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational StudyCompletedNCT02593799
- Comparison of Smart-Shear Wave Elastography and Transient ElastographyStatus unknownNCT02569567
- Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary CirrhosisCompletedNCT02557360Phase 4
- Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver CirrhosisCompletedNCT02551250
- Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and SteatosisStatus unknownNCT02542020
- A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the BodyCompletedNCT02538874Phase 1
- To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill CirrhosisCompletedNCT02528760Not applicable
- Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosisWithdrawnNCT02526303Not applicable
- Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]Status unknownNCT02514434Not applicable
- Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic HydrothoraxCompletedNCT02508688Not applicable
- Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal VaricesStatus unknownNCT02508623Phase 3
- Surrogate Markers of Portal PressureCompletedNCT02508298Not applicable
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisCompletedNCT02499562Phase 2
- TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein ThrombosisStatus unknownNCT02485184Not applicable
- Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)Status unknownNCT02484573Not applicable
- Thrombin Generation Test in Patient With Liver CirrhosisCompletedNCT02484534
- Zinc Supplementation in Cirrhotic PatientsStatus unknownNCT02475928Not applicable
- Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver CirrhosisStatus unknownNCT02473601Phase 2
- Metformin Experience on Minimal Hepatic EncephalopathyStatus unknownNCT02470546Phase 4
- Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver CirrhosisCompletedNCT02468479
- To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic ShockCompletedNCT02468063Not applicable
- To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.WithdrawnNCT02465619
- To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated CirrhosisTerminatedNCT02464631Not applicable
- Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced HypotensionCompletedNCT02462902Not applicable
- Alfapump-albumin Replacement TherapyTerminatedNCT02448160Not applicable
- Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)CompletedNCT02439567Not applicable
- Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal BacterialTerminatedNCT02439307Not applicable
- Biomarkers of Liver FibrosisTerminatedNCT02438917
- Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic PatientsStatus unknownNCT02427906
- Lean Mass Evaluation of Cirrhotic Patients With Ascites With the Use DXACompletedNCT02421848
- High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic EncephalopathyTerminatedNCT02418039Not applicable
- The Use of Fibroscan to Assess Liver Fibrosis in Patients With Cardiac PacemakersStatus unknownNCT02415348Not applicable
- Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver ResectionCompletedNCT02414880Phase 4
- Late Evening Supplementation With Branched Chain Amino Acids in Liver TransplantationStatus unknownNCT02407769Not applicable
- Infrahepatic Inferior Vena Cava Clamping Versus Selective Hepatic Vascular Exclusion Involving the Portal Triad ClampingStatus unknownNCT02405416Not applicable
- Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic EncephalopathyStatus unknownNCT02401490Phase 4
- The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein ThrombosisStatus unknownNCT02398357Phase 4
- Relationship Between HbA1c and Chronic Glycemia in Patients With CirrhosisCompletedNCT02389127
- The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal BleedingStatus unknownNCT02385422Phase 4
- Early Use of TIPSS in Patients With Cirrhosis and Variceal BleedingCompletedNCT02377141Not applicable
- B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary CirrhosisCompletedNCT02376335Phase 2
- Exercise Intervention in Liver Transplant PatientsCompletedNCT02367092Not applicable
- Thromboelastographic Guide for Blood Products in CirrhoticsCompletedNCT02362178Phase 2
- IBAT Inhibitor A4250 for Cholestatic PruritusTerminatedNCT02360852Phase 2
- Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic SyndromeCompletedNCT02353767
- Development of a Novel Biomarker for Liver FibrosisCompletedNCT02348814
- Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver CirrhosisStatus unknownNCT02344823Phase 4
- Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver CirrhosisCompletedNCT02344719Phase 4
- The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver CirrhosisStatus unknownNCT02343653Not applicable
- Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic FibrosisCompletedNCT02342964Not applicable
- Effect of Portal Vein Thrombosis on the Prognosis of Liver CirrhosisCompletedNCT02335580
- Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver CirrhosisCompletedNCT02335073
- Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous DiabetesStatus unknownNCT02325622
- Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant CapacitiesStatus unknownNCT02321579Not applicable
- An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary CirrhosisWithdrawnNCT02321306Phase 2
- Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
- Cirrhosis Readmission Telehealth ProjectTerminatedNCT02313896Not applicable
- ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis BCompletedNCT02313649
- Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical TrialTerminatedNCT02311985Not applicable
- Effects of Terlipressin When Usual Somatostatin or Octreotide Dose FailsStatus unknownNCT02311608
- Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver CirrhosisCompletedNCT02297867Phase 1
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer PatientsWithdrawnNCT02289300Phase 2
- Portal Vein Thrombosis in CirrhosisWithdrawnNCT02275585
- Effects of Home Based Exercise Therapy in Early CirrhosisCompletedNCT02267421Not applicable
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related ParkinsonismCompletedNCT02265484Not applicable
- The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early CirrhosisWithdrawnNCT02258048
- Open Label Trial of Immunotherapy for Advanced Liver CancerStatus unknownNCT02256514Phase 2
- A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting ConditionsCompletedNCT02254434Phase 1
- Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate SupplementationCompletedNCT02249741Phase 4
- Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBVStatus unknownNCT02241616Phase 4
- Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02241590Phase 4
- Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver TransplantStatus unknownNCT02239991Not applicable
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin ResistanceCompletedNCT02234440Not applicable
- Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis CCompletedNCT02226939Phase 2
- Baclofen in the Treatment of Muscle Cramps in Patients With CirrhosisStatus unknownNCT02221570Not applicable
- An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced CirrhosisCompletedNCT02195440Phase 1
- Pilot Study of FFP104 Dose Escalation in PBC SubjectsStatus unknownNCT02193360Phase 1/2
- Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled TrialStatus unknownNCT02190357Phase 4
- The Role of Strain Elastography in Staging Liver FibrosisStatus unknownNCT02184000
- Liver Fibrosis Assessment With ShearWave ElastographyCompletedNCT02181452
- Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled TrialStatus unknownNCT02178319Not applicable
- An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe PsoriasisStatus unknownNCT02174367
- Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent AscitesCompletedNCT02173288Phase 2/3
- Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver DiseasesStatus unknownNCT02171949Phase 2
- Frequent Ketamine Use and Gastrointestinal, Liver and Biliary SequelaeCompletedNCT02165488
- Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory AscitesCompletedNCT02163512
- Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic EncephalopathyCompletedNCT02156232Not applicable
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 CirrhosisCompletedNCT02151864Phase 1
- Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot StudyStatus unknownNCT02147470Not applicable
- Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary CirrhosisCompletedNCT02135536Phase 2
- Simvastatin Effect on Portal HypertensionCompletedNCT02134626Phase 3
- Sarcopenia and CirrhosisCompletedNCT02132962Not applicable